<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02391896</url>
  </required_header>
  <id_info>
    <org_study_id>14-7549-CE</org_study_id>
    <nct_id>NCT02391896</nct_id>
  </id_info>
  <brief_title>Design and Evaluation of Mobile X-ray for Rapid and Accurate Diagnosis of Thoracic Disease</brief_title>
  <official_title>Design and Evaluation of Innovative Mobile X-Ray Technology for Rapid and Accurate Diagnosis of Thoracic Disease in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Carestream Health, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Computed tomography (CT) is the most accurate test for evaluating patients with thoracic&#xD;
      disease. However, access to CT is limited due to long wait times and for the sickest patients&#xD;
      in Hospital who cannot be transported from the ward to the CT scanner. The investigators&#xD;
      propose to modify a standard X-ray unit to provide more detailed information of the chest&#xD;
      such that a CT scan is not required for all patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dual-energy (DE) imaging consists of acquiring paired &quot;low&quot; and &quot;high&quot;-energy x-ray images.&#xD;
      The use of DE to improve radiological contrast was first described by Jacobson et al in 1958;&#xD;
      followed by Mistretta et al and Alvarez and Macovski in the mid-1970s. With the advent of new&#xD;
      digital X-ray detectors that provide high dose efficiency and rapid readout of digital X-ray&#xD;
      projections, there has been renewed interest in using DE x-ray imaging for lung nodule&#xD;
      detection. More recently, portable x-ray detectors have made bedside DE imaging possible.&#xD;
      Jabri et. al. presented a portable DE system with novel respiratory and cardiac gating, and&#xD;
      Hoggarth et. al. investigated the potential for DE subtraction in improving the visualization&#xD;
      of lung tumors while performing image-guided radiotherapy.&#xD;
&#xD;
      The investigators group is experienced in investigating DE for lung nodule detection, this&#xD;
      theoretical framework was instrumental in optimizing a clinical prototype for&#xD;
      high-performance DE chest X-ray. It identified optimal DE image acquisition and decomposition&#xD;
      techniques, and validated the approach in comparison to human observer performance. The&#xD;
      analysis further demonstrated that - given a high-performance flat plate detector, optimal&#xD;
      acquisition and decomposition - DE chest X-ray is possible at the same dose as conventional&#xD;
      computer radiography (CR) and digital radiography (DR) chest X-ray, while significantly&#xD;
      improving conspicuity of subtle lung nodules by the reduction of overlying background noise.&#xD;
      The DE work undertaken by our group is unique in terms of providing a clear theoretical&#xD;
      framework for optimizing a clinical prototype for best performance in terms of image quality&#xD;
      and patient exposure to ionizing radiation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI has left UHN. This study is no longer running at UHN.&#xD;
  </why_stopped>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improved detection of maliganancy with modified x-ray</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Thoracic Diseases</condition>
  <arm_group>
    <arm_group_label>Digital Tomosynthesis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient will get tomosynthesis scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dual energy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient will get dual energy scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dual energy and tomosynthesis xray</intervention_name>
    <arm_group_label>Digital Tomosynthesis</arm_group_label>
    <arm_group_label>Dual energy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  the presence of lung disease (nodules, masses, consolidation and collapse), pleural&#xD;
             disease (effusion, thickening), mediastinal and hilar lymph node enlargement, on&#xD;
             thoracic CT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unable to consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Narinder Paul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Toronto General Hospital, Department of Medical Imaging</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>March 12, 2015</study_first_submitted>
  <study_first_submitted_qc>March 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2015</study_first_posted>
  <last_update_submitted>October 23, 2018</last_update_submitted>
  <last_update_submitted_qc>October 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thoracic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

